Header Logo

Connection

Edward Stanek to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Back to Details
This is a "connection" page, showing publications Edward Stanek has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Edward Stanek
Connection Strength
0.362
Hydroxymethylglutaryl-CoA Reductase Inhibitors
  1. Charland SL, Agatep BC, Herrera V, Schrader B, Frueh FW, Ryvkin M, Shabbeer J, Devlin JJ, Superko HR, Stanek EJ. Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial. Pharmacogenomics J. 2014 Jun; 14(3):272-80.
    View in: PubMed
    Score: 0.362
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.